The goal of the project is to create a continuous loop: "model → physical experiment → data validation." AI is no longer limited to generating text or code; Claude algorithms are beginning to synthesize new pathogens and molecular structures in vitro. For the DeepTech and pharmaceutical sectors, this signifies the imminent death of traditional drug discovery methods. Big Tech is monopolizing not only cloud computing but also applied biology, combining server teraflops with chemical reactors to dominate the multi-billion dollar healthcare market.
Source: Anthropic / Reuters
DeepTechAnthropicBioTechB2BMacroeconomics